Mednax Inc Market Cap ($2.15 Billion)
Market Cap & Net Worth: Mednax Inc (MD)
Mednax Inc market cap. Mednax Inc (NYSE:MD) has a market capitalization of $2.15 Billion ($2.15 Billion) as of October 31, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #5720 globally and #1893 in its home market, demonstrating a 3.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mednax Inc's stock price $29.18 by its total outstanding shares 81253271 (81.25 Million).
Mednax Inc Market Cap History (2015–2026)
Mednax Inc market cap history from 2015 to 2026. Data shows change from $5.82 Billion to $2.37 Billion (-8.77% CAGR). Check Mednax Inc stock quote for real-time trading data and today's change.
Index Memberships
Mednax Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.58 Trillion | 0.10% | #292 of 602 |
Weight: Mednax Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Mednax Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mednax Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Mednax Inc (MD) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.91x
Mednax Inc's market cap is 0.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.51x
Mednax Inc's market cap is 10.51 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.42 Billion | $3.18 Billion | $324.91 Million | 1.70x | 16.67x |
| 2017 | $4.34 Billion | $3.46 Billion | $320.37 Million | 1.26x | 13.55x |
| 2018 | $2.68 Billion | $3.65 Billion | $268.63 Million | 0.74x | 9.98x |
| 2019 | $2.26 Billion | $1.78 Billion | -$1.50 Billion | 1.27x | N/A |
| 2020 | $1.99 Billion | $1.73 Billion | -$796.49 Million | 1.15x | N/A |
| 2021 | $2.21 Billion | $1.91 Billion | $130.96 Million | 1.16x | 16.88x |
| 2022 | $1.21 Billion | $1.97 Billion | $66.33 Million | 0.61x | 18.20x |
| 2023 | $755.66 Million | $1.99 Billion | -$60.41 Million | 0.38x | N/A |
| 2024 | $1.07 Billion | $2.01 Billion | -$99.07 Million | 0.53x | N/A |
| 2025 | $1.74 Billion | $1.91 Billion | $165.39 Million | 0.91x | 10.51x |
Competitor Companies of MD by Market Capitalization
Companies near Mednax Inc in the global market cap rankings as of October 31, 2026. See MD equity financing ratio to understand what proportion of total assets are financed by equity.
Key companies related to Mednax Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #290 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #907 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #993 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1215 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #290 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $478.08 |
| #907 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.00 |
| #993 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1215 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $270.57 |
Market Capitalization of Mednax Inc (2015–2026)
Market capitalization of Mednax Inc from 2015 to today. Between 2015 and today, Mednax Inc's market cap moved from $5.82 Billion to $ 2.37 Billion, with a yearly change of -8.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.37 Billion | +36.42% |
| 2025 | $1.74 Billion | +63.03% |
| 2024 | $1.07 Billion | +41.08% |
| 2023 | $755.66 Million | -37.42% |
| 2022 | $1.21 Billion | -45.39% |
| 2021 | $2.21 Billion | +10.88% |
| 2020 | $1.99 Billion | -11.69% |
| 2019 | $2.26 Billion | -15.79% |
| 2018 | $2.68 Billion | -38.25% |
| 2017 | $4.34 Billion | -19.83% |
| 2016 | $5.42 Billion | -6.98% |
| 2015 | $5.82 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Mednax Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.15 Billion USD |
| MoneyControl | $2.15 Billion USD |
| MarketWatch | $2.15 Billion USD |
| marketcap.company | $2.15 Billion USD |
| Reuters | $2.15 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners,… Read more